1-11 of 11
Thomas Tousseyn, MD, PhD
Close
Sort by
Journal Articles

Unraveling the Landscape of Copy Number Aberrations in Hodgkin Lymphoma: A Joint KU Leuven and Lysa Study on Circulating Cell Free DNA

Lieselot Buedts, Luc Mathieu Fornecker, Julio Finalet-Ferreiro, PhD, Luc Dehaspe, PhD, Thomas Tousseyn, MD PhD, Olivier Gheysens, MD PhD, Julien Lazarovici, MD, Rene-Olivier Casasnovas, MD, Christiane Copie, MD PhD, Gregor Verhoef, MD PhD, Sanne Smits, Joris Vermeesch, PhD, Marc Andre, MD PhD, Peter Vandenberghe, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2836.
https://doi.org/10.1182/blood-2018-99-113402
Published: 2018
Journal Articles

Use of Bortezomib-Containing Regimens in the Frontline Treatment of Patients with Plasmablastic Lymphoma: A Multicenter Retrospective Analysis

Thomas Guerrero, MD, Michele Bibas, MD, Franco Baldini, MD, Guillaume Cartron, Kate Cwynarski, MD, Daan Dierickx, MD PhD, Frederick Lansigan, MD, Yevgeniy A Linnik, MD, Renzo Mogollon, MD, Jose Tomas Navarro, MD PhD, Slavisa Ninkovic, MBBS FRACP FRCPA, Adam J Olszewski, MD, John L. Reagan, MD, Emmanuelle Tchernonog, MD, Thomas Tousseyn, MD PhD, Jorge J. Castillo, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1580.
https://doi.org/10.1182/blood.V130.Suppl_1.1580.1580
Published: 2017
Journal Articles

Involvement of FER and FES in the Pathogenesis of Follicular Variant of Peripheral T-Cell Lymphoma

Iwona Wlodarska, PhD, Jo-Anne van der Krogt, Msc, Katrien Van Roosbroeck, PhD, Julio Finalet Ferreiro, Msc, Thomas Tousseyn, MD PhD, Carlos Graux, MD PhD, Daan Dierickx, MD PhD, Peter Vandenberghe, MD PhD, Jan Cools, PhD
Journal: Blood
Blood (2014) 124 (21): 5194.
https://doi.org/10.1182/blood.V124.21.5194.5194
Published: 2014
Journal Articles

Convergent Mutations and New Kinase Fusions Lead to Oncogenic STAT3 Activation in Anaplastic Large Cell Lymphoma

Ramona Crescenzo, MS, Francesco Abate, Elena Lasorsa, PhD, Fabrizio Tabbo', MD, Marcello Gaudiano, Nicoletta Chiesa, PhD, Filomena Di Giacomo, MS, Elisa Spaccarotella, PhD, Luigi Barbarossa, MS, Maria Todaro, PhDstudent, Michela Boi, PhD, Thomas Tousseyn, MD PhD, Andreas Rosenwald, MD, Lukas Kenner, MD, Davide Rossi, MD PhD, Laurence Mevellec, Jorge Vialard, Francesco Bertoni, Raul Rabadan, PhD, Giorgio Inghirami, MD
Journal: Blood
Blood (2014) 124 (21): 781.
https://doi.org/10.1182/blood.V124.21.781.781
Published: 2014
Journal Articles

Non- IG Aberrations of FOXP1 in B-Cell Malignancies Result in an Aberrant Expression of N-Truncated FOXP1 Isoforms.

Iwona Wlodarska, PhD, Leila Rouhi, MD, Julio Finalet Ferreiro, M Sc, Thomas Tousseyn, MD PhD, Natalie Put, MD, Eugenia Haralambieva, MD, PhD, Carlos Graux, MD, PhD, Brigitte Maes, MD, PhD, Carmen Vicente, PhD, Peter Vandenberghe, MD, PhD, Jan Cools, PhD
Journal: Blood
Blood (2012) 120 (21): 2411.
https://doi.org/10.1182/blood.V120.21.2411.2411
Published: 2012
Journal Articles

The Accuracy of PET in the Detection of Posttransplant Lymphoproliferative Disorder (PTLD)

Daan Dierickx, MD, Gregor Verhoef, Olivier Gheysens, MD, Thomas Tousseyn, MD PhD, Christiane De Wolf-Peeters, MD PhD, Iwona Wlodarska, PhD, Lieselot Brepoels, MD
Journal: Blood
Blood (2011) 118 (21): 2657.
https://doi.org/10.1182/blood.V118.21.2657.2657
Published: 2011
Journal Articles

JAK2 , As Well As PDL1 and PDL2 , are Recurrently Targeted by 9p24 Structural and Numerical Aberrations in Lymphoid Neoplasms of Both B- and T-Cell Origin

Katrien Van Roosbroeck, PhD, Thomas Tousseyn, MD PhD, Julio Finalet Ferreiro, M Sc, Idoya Lahortiga, PhD, Lucienne Michaux, MD PhD, Barbara Cauwelier, PhD, Barbara Pienkowska-Grela, PhD, Gregor Verhoef, Chantal Doyen, MD, Ivan Theate, MD, Christiane De Wolf-Peeters, MD PhD, Peter Vandenberghe, MD, PhD, Iwona Wlodarska, PhD
Journal: Blood
Blood (2011) 118 (21): 2460.
https://doi.org/10.1182/blood.V118.21.2460.2460
Published: 2011
Journal Articles

BLIMP1 Is Commonly Inactivated In Anaplastic Large T-Cell Lymphomas (ALCL)

Michela Boi, Andrea Rinaldi, Roberto Piva, Paola MV Rancoita, PhD, Paola Bonetti, Andras Matolcsy, MD, Thomas Tousseyn, MD PhD, Socorro Maria Rodríguez-Pinilla, Miguel Piris, MD, Sílvia Beà, Elias Campo, MD, Govind Bhagat, M.D., Steven H. Swerdlow, MD, Andreas Rosenwald, MD, Maurilio Ponzoni, MD, Ken H. Young, MD, Pier Paolo Piccaluga, Stefano Pileri, MD, Antonino Neri, Enzo Medico, Emanuele Zucca, MD, Ivo Kwee, Giorgio Inghirami, Francesco Bertoni, MD
Journal: Blood
Blood (2011) 118 (21): 2634.
https://doi.org/10.1182/blood.V118.21.2634.2634
Published: 2011
Journal Articles

T(X;14)(p11.4;q32.33) Is Recurrent In Marginal Zone Lymphoma and Upregulates GPR34

Iwona Wlodarska, PhD, Julio Finalet Ferreiro, M Sc, Thomas Tousseyn, MD PhD, Helena Urbankova, PhD, Lucienne Michaux, MD PhD, Laurence de Leval, MD PhD, Daan Dierickx, MD, Pascal Wolter, MD PhD, Xavier Sagaert, MD PhD, Peter Vandenberghe, MD, PhD, Christiane De Wolf-Peeters, MD PhD, Mathijs Baens, PhD
Journal: Blood
Blood (2011) 118 (21): 1349.
https://doi.org/10.1182/blood.V118.21.1349.1349
Published: 2011
Journal Articles

BMI1 , the Polycomb-Group Gene, Is Recurrently Targeted by Genomic Rearrangements in Progressive B-Cell Leukemia/Lymphoma.

Leila Rouhi, MD, Natalie Put, MD, Thomas Tousseyn, MD, PhD, Julio Finalet Ferreiro, Wim De Kelver, Hilde Demuynck, MD, Johan Verschuere, MD, Ivan Théate, MD, Carmen Vicente, Lucienne Michaux, MD, PhD, Chris De Wolf-Peeters, MD, PhD, Peter Vandenberghe, MD, PhD, Jan Cools, PhD, Iwona Wlodarska, PhD
Journal: Blood
Blood (2009) 114 (22): 1099.
https://doi.org/10.1182/blood.V114.22.1099.1099
Published: 2009
Journal Articles

JAK2 Rearrangements, Including the Novel SEC31A-JAK2 Fusion, Are Recurrent in Classical Hodgkin Lymphoma.

Katrien Van Roosbroeck, Luk Cox, PhD, Idoya Lahortiga, PhD, Olga Gielen, Thomas Tousseyn, MD, PhD, Barbara Cauwelier, PhD, Pascale De Paepe, MD, PhD, Peter Vandenberghe, MD, PhD, Peter Marynen, PhD, Chris De Wolf-Peeters, MD, PhD, Jan Cools, PhD, Iwona Wlodarska, PhD
Journal: Blood
Blood (2009) 114 (22): 140.
https://doi.org/10.1182/blood.V114.22.140.140
Published: 2009